Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 34 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

9%

3 trials in Phase 3/4

Results Transparency

0%

0 of 29 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
13(76.5%)
Phase 4
2(11.8%)
Phase 2
1(5.9%)
Phase 3
1(5.9%)
17Total
N/A(13)
Phase 4(2)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (34)

Showing 20 of 34 trials
NCT06940791Phase 2Recruiting

Tirabrutinib Maintenance Versus Placebo in Patients With Primary CNS Lymphoma in Complete Remission (JCOG2104)

Role: lead

NCT02761070Phase 3Unknown

Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III

Role: lead

NCT02729662Not ApplicableUnknown

Efficacy of Tolvaptan on ADPKD Patients

Role: lead

NCT03244007Completed

Evaluation of Retinal Microstructure Detected With Intraoperative Optical Coherence Tomography During Vitrectomy

Role: lead

NCT03522311Completed

Surgical Outcomes for Proliferative Diabetic Retinopathy by Preoperative Glycemic Control and Renal Function

Role: lead

NCT01348035Completed

Efficacy Study of Water Drinking on PKD Progression.

Role: lead

NCT03376776Completed

Epiretinal Proliferation in Eyes With Full Thickness Macular Hole

Role: lead

NCT02322385Completed

Clinical Implications of DNA Analysis on ADPKD

Role: lead

NCT02896972Not ApplicableCompleted

Inverted Internal Limiting Membrane Flap Technique for Macular Hole Retinal Detachment in Highly Myopic Eyes

Role: lead

NCT02462304Phase 4Unknown

To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular Edema

Role: collaborator

NCT02650739Completed

Optical Coherence Tomography-based Positioning for Macular Hole Surgery

Role: lead

NCT02628158Completed

Fundus Autofluorescence After Vitrectomy for Epiretinal Membrane

Role: lead

NCT02528045Completed

Vitrectomy and Scleral Shortening for Macular Hole Retinal Detachment or Myopic Traction Maculopathy

Role: lead

NCT02528058Completed

Ultrastructure Analysis of Excised Internal Limiting Membrane in Eyes of Highly Myopia With Myopic Traction Maculopathy

Role: lead

NCT02464800Completed

Efficacy of Higher Cutting Rate in Microincision Vitrectomy for Proliferative Diabetic Retinopathy

Role: lead

NCT01674023Completed

MicroRNA Expression Profile in Human Vitreous of Patients With Various Vitreoretinal Diseases Requiring Vitrectomy

Role: lead

NCT01462734Completed

MicroRNA Expression in Human Blood Serum and Vitreous Body

Role: lead

NCT01862627Completed

Macular Retinoschisis and Detachment Associated With Glaucomatous Optic Neuropathy

Role: lead

NCT02120066Not ApplicableCompleted

Submacular Hemorrhage Associated With Retinal Arterial Macro Aneurysm

Role: lead

NCT01959776Not ApplicableCompleted

Asymmetrical Recovery of Cone Outer Segment Tips and Foveal Displacement After Macular Hole Surgery

Role: lead